Press Release: Noventure acquires Ulkox® and Oleoabrax®, two medical devices based on patented new wound-healing technology
• Acquisition allows Noventure to maintain focus on medical devices and grow therapeutic areas in which it operates
• Medical devices contain Olea Europaea leaf extract, showing healing properties for ulcers and skin wounds
• Innovative products are CE marked and available for licensing worldwide
Barcelona, Spain, April 19, 2021 – Noventure, specialized in licensing innovative substance-based medical devices and specialist food supplements, today announces it has acquired the Ulkox® and Oleoabrax® products, based on an Olea Europaea leaf extract wound-healing technology.